CLB Relative Valuation
CLB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CLB is overvalued; if below, it's undervalued.
Historical Valuation
Core Laboratories Inc (CLB) is now in the Fair zone, suggesting that its current forward PE ratio of 22.19 is considered Fairly compared with the five-year average of 26.62. The fair price of Core Laboratories Inc (CLB) is between 15.18 to 27.64 according to relative valuation methord.
Relative Value
Fair Zone
15.18-27.64
Current Price：16.31
Fair
22.28
PE
1Y
3Y
5Y
Trailing
Forward
11.94
EV/EBITDA
Core Laboratories Inc. (CLB) has a current EV/EBITDA of 11.94. The 5-year average EV/EBITDA is 15.79. The thresholds are as follows: Strongly Undervalued below 5.75, Undervalued between 5.75 and 10.77, Fairly Valued between 20.82 and 10.77, Overvalued between 20.82 and 25.84, and Strongly Overvalued above 25.84. The current Forward EV/EBITDA of 11.94 falls within the Historic Trend Line -Fairly Valued range.
15.69
EV/EBIT
Core Laboratories Inc. (CLB) has a current EV/EBIT of 15.69. The 5-year average EV/EBIT is 20.59. The thresholds are as follows: Strongly Undervalued below 5.53, Undervalued between 5.53 and 13.06, Fairly Valued between 28.12 and 13.06, Overvalued between 28.12 and 35.65, and Strongly Overvalued above 35.65. The current Forward EV/EBIT of 15.69 falls within the Historic Trend Line -Fairly Valued range.
1.47
PS
Core Laboratories Inc. (CLB) has a current PS of 1.47. The 5-year average PS is 1.97. The thresholds are as follows: Strongly Undervalued below 0.60, Undervalued between 0.60 and 1.29, Fairly Valued between 2.66 and 1.29, Overvalued between 2.66 and 3.34, and Strongly Overvalued above 3.34. The current Forward PS of 1.47 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Core Laboratories Inc. (CLB) has a current P/OCF of 0.00. The 5-year average P/OCF is 18.88. The thresholds are as follows: Strongly Undervalued below 1.24, Undervalued between 1.24 and 10.06, Fairly Valued between 27.70 and 10.06, Overvalued between 27.70 and 36.52, and Strongly Overvalued above 36.52. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
Core Laboratories Inc. (CLB) has a current P/FCF of 0.00. The 5-year average P/FCF is 26.03. The thresholds are as follows: Strongly Undervalued below -4.45, Undervalued between -4.45 and 10.79, Fairly Valued between 41.28 and 10.79, Overvalued between 41.28 and 56.52, and Strongly Overvalued above 56.52. The current Forward P/FCF of 0.00 falls within the Undervalued range.
Core Laboratories Inc (CLB) has a current Price-to-Book (P/B) ratio of 2.79. Compared to its 3-year average P/B ratio of 3.82 , the current P/B ratio is approximately -26.94% higher. Relative to its 5-year average P/B ratio of 6.23, the current P/B ratio is about -55.25% higher. Core Laboratories Inc (CLB) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 3.44%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 2.75% , the current FCF yield is about -100.00% lower.
2.80
P/B
Median3y
3.82
Median5y
6.23
4.50
FCF Yield
Median3y
3.44
Median5y
2.75
Competitors Valuation Multiple
The average P/S ratio for CLB's competitors is , providing a benchmark for relative valuation. Core Laboratories Inc Corp (CLB) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 0.09%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of CLB decreased by 4.74% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 8.93 to 10.80.
The secondary factor is the Revenue Growth, contributed 0.09%to the performance.
Overall, the performance of CLB in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is Core Laboratories Inc (CLB) currently overvalued or undervalued?
What is Core Laboratories Inc (CLB) fair value?
How does CLB's valuation metrics compare to the industry average?
What is the current P/B ratio for Core Laboratories Inc (CLB) as of Dec 05 2025?
What is the current FCF Yield for Core Laboratories Inc (CLB) as of Dec 05 2025?
What is the current Forward P/E ratio for Core Laboratories Inc (CLB) as of Dec 05 2025?